{"nct_id":"NCT01171989","title":"Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose","status":"COMPLETED","status_verified_date":"2020-01","start_date":"2010-08-18","start_date_type":"ACTUAL","primary_completion_date":"2010-12-03","primary_completion_date_type":"ACTUAL","completion_date":"2010-12-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}